漢思能源(00554.HK)支持城巴興建全港首個加氫站
漢思能源(00554.HK)宣布,間接持有15.56%股權的城巴將在西九龍車廠興建香港首個加氫站,旨在配合政府明年於香港測試氫燃料電池巴士的計劃,而集團將作為此加氫站的主要投資者,積極參與興建。
在獲得政府相關批准後,預計加氫站最早可於2023年第一季投入使用,料可以為由城巴擁有及營運的全球首輛三軸雙層氫燃料電池巴士提供加氫服務。
漢思能源行政總裁兼匯達交通董事楊冬表示,加氫站作為氫能車不可或缺的供氫配套設施,集團參與投資興建香港第一座加氫站,顯示出作為股東對城巴發展氫能巴士計劃的全力支持,同時也是集團從傳統能源業務邁向新能源業務特別是氫能產業的重要一步。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.